127 related articles for article (PubMed ID: 19432894)
1. High throughput analysis of proteins associating with a proinvasive MT1-MMP in human malignant melanoma A375 cells.
Tomari T; Koshikawa N; Uematsu T; Shinkawa T; Hoshino D; Egawa N; Isobe T; Seiki M
Cancer Sci; 2009 Jul; 100(7):1284-90. PubMed ID: 19432894
[TBL] [Abstract][Full Text] [Related]
2. Increased aggressiveness of human prostate PC-3 tumor cells expressing cell surface localized membrane type-1 matrix metalloproteinase (MT1-MMP).
Wang X; Wilson MJ; Slaton JW; Sinha AA; Ewing SL; Pei D
J Androl; 2009; 30(3):259-74. PubMed ID: 19136391
[TBL] [Abstract][Full Text] [Related]
3. Expression of E1AF, an ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene.
Hata H; Kitamura T; Higashino F; Hida K; Yoshida K; Ohiro Y; Totsuka Y; Kitagawa Y; Shindoh M
Oncol Rep; 2008 May; 19(5):1093-8. PubMed ID: 18425363
[TBL] [Abstract][Full Text] [Related]
4. Identification of proteins that associate with integrin α2 by proteomic analysis in human fibrosarcoma HT-1080 cells.
Uematsu T; Konishi C; Hoshino D; Han X; Tomari T; Egawa N; Takada Y; Isobe T; Seiki M; Koshikawa N
J Cell Physiol; 2012 Aug; 227(8):3072-9. PubMed ID: 21989839
[TBL] [Abstract][Full Text] [Related]
5. Substrate choice of membrane-type 1 matrix metalloproteinase is dictated by tissue inhibitor of metalloproteinase-2 levels.
Kudo T; Takino T; Miyamori H; Thompson EW; Sato H
Cancer Sci; 2007 Apr; 98(4):563-8. PubMed ID: 17425593
[TBL] [Abstract][Full Text] [Related]
6. Polarized MT1-MMP-CD44 interaction and CD44 cleavage during cell retraction reveal an essential role for MT1-MMP in CD44-mediated invasion.
Marrero-Diaz R; Bravo-Cordero JJ; Megías D; García MA; Bartolomé RA; Teixido J; Montoya MC
Cell Motil Cytoskeleton; 2009 Jan; 66(1):48-61. PubMed ID: 19023892
[TBL] [Abstract][Full Text] [Related]
7. Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice.
Taniwaki K; Fukamachi H; Komori K; Ohtake Y; Nonaka T; Sakamoto T; Shiomi T; Okada Y; Itoh T; Itohara S; Seiki M; Yana I
Cancer Res; 2007 May; 67(9):4311-9. PubMed ID: 17483344
[TBL] [Abstract][Full Text] [Related]
8. Membrane-type 1 matrix metalloproteinase stimulates cell migration through epidermal growth factor receptor transactivation.
Langlois S; Nyalendo C; Di Tomasso G; Labrecque L; Roghi C; Murphy G; Gingras D; Béliveau R
Mol Cancer Res; 2007 Jun; 5(6):569-83. PubMed ID: 17541067
[TBL] [Abstract][Full Text] [Related]
9. CDCP1 regulates the function of MT1-MMP and invadopodia-mediated invasion of cancer cells.
Miyazawa Y; Uekita T; Ito Y; Seiki M; Yamaguchi H; Sakai R
Mol Cancer Res; 2013 Jun; 11(6):628-37. PubMed ID: 23439492
[TBL] [Abstract][Full Text] [Related]
10. CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase.
Suenaga N; Mori H; Itoh Y; Seiki M
Oncogene; 2005 Jan; 24(5):859-68. PubMed ID: 15558018
[TBL] [Abstract][Full Text] [Related]
11. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia.
Poincloux R; Lizárraga F; Chavrier P
J Cell Sci; 2009 Sep; 122(Pt 17):3015-24. PubMed ID: 19692588
[TBL] [Abstract][Full Text] [Related]
12. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.
Nishida Y; Miyamori H; Thompson EW; Takino T; Endo Y; Sato H
Cancer Res; 2008 Nov; 68(21):9096-104. PubMed ID: 18974156
[TBL] [Abstract][Full Text] [Related]
13. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
[TBL] [Abstract][Full Text] [Related]
14. MT1-MMP shedding involves an ADAM and is independent of its localization in lipid rafts.
Toth M; Sohail A; Mobashery S; Fridman R
Biochem Biophys Res Commun; 2006 Nov; 350(2):377-84. PubMed ID: 17007816
[TBL] [Abstract][Full Text] [Related]
15. Impaired tyrosine phosphorylation of membrane type 1-matrix metalloproteinase reduces tumor cell proliferation in three-dimensional matrices and abrogates tumor growth in mice.
Nyalendo C; Beaulieu E; Sartelet H; Michaud M; Fontaine N; Gingras D; Béliveau R
Carcinogenesis; 2008 Aug; 29(8):1655-64. PubMed ID: 18621744
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of MT1-MMP is insufficient to increase experimental liver metastasis of human colon cancer cells.
Yamamoto H; Noura S; Okami J; Uemura M; Takemasa I; Ikeda M; Ishii H; Sekimoto M; Matsuura N; Monden M; Mori M
Int J Mol Med; 2008 Dec; 22(6):757-61. PubMed ID: 19020773
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of membrane-type 1 matrix metalloproteinase at cell-matrix adhesions.
Takino T; Saeki H; Miyamori H; Kudo T; Sato H
Cancer Res; 2007 Dec; 67(24):11621-9. PubMed ID: 18089791
[TBL] [Abstract][Full Text] [Related]
18. MT1-MMP-dependent invasion is regulated by TI-VAMP/VAMP7.
Steffen A; Le Dez G; Poincloux R; Recchi C; Nassoy P; Rottner K; Galli T; Chavrier P
Curr Biol; 2008 Jun; 18(12):926-31. PubMed ID: 18571410
[TBL] [Abstract][Full Text] [Related]
19. MT1-MMP modulates melanoma cell dissemination and metastasis through activation of MMP2 and RAC1.
Shaverdashvili K; Wong P; Ma J; Zhang K; Osman I; Bedogni B
Pigment Cell Melanoma Res; 2014 Mar; 27(2):287-96. PubMed ID: 24387669
[TBL] [Abstract][Full Text] [Related]
20. Secretion of active membrane type 1 matrix metalloproteinase (MMP-14) into extracellular space in microvesicular exosomes.
Hakulinen J; Sankkila L; Sugiyama N; Lehti K; Keski-Oja J
J Cell Biochem; 2008 Dec; 105(5):1211-8. PubMed ID: 18802920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
